Natural Capsules Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹142.55
Market cap
148 Cr
P/B
0.63
Dividend yield
0.6%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales38 Cr38 Cr40 Cr40 Cr39 Cr41 Cr44 Cr45 Cr45 Cr46 Cr38 Cr58 Cr
Operating expenses (approx.)32 Cr32 Cr35 Cr36 Cr35 Cr37 Cr40 Cr40 Cr45 Cr47 Cr40 Cr56 Cr
EBITDA6 Cr5 Cr5 Cr4 Cr4 Cr5 Cr4 Cr5 Cr0.68 Cr-0.72 Cr-2 Cr2 Cr
OPM %15.8%13.6%11.8%10.2%11.1%10.9%9.7%10.4%1.5%-1.6%-5.0%3.6%
Other income0.17 Cr0.35 Cr0.50 Cr0.92 Cr0.18 Cr0.11 Cr0.11 Cr0.30 Cr0.36 Cr0.16 Cr0.45 Cr0.76 Cr
Interest1 Cr1 Cr1 Cr1 Cr1 Cr2 Cr2 Cr2 Cr3 Cr3 Cr3 Cr3 Cr
Depreciation2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr4 Cr4 Cr4 Cr4 Cr
Profit before tax3 Cr2 Cr2 Cr1 Cr0.77 Cr0.62 Cr0.50 Cr0.89 Cr-6 Cr-8 Cr-9 Cr-5 Cr
Tax %32.3%27.1%32.8%32.2%22.1%199.4%79.0%41.6%8.0%9.2%21.7%2.0%
Net profit2 Cr2 Cr1 Cr0.97 Cr0.60 Cr-0.61 Cr0.11 Cr0.52 Cr-6 Cr-7 Cr-7 Cr-5 Cr
EPS (₹)₹1.96₹1.67₹1.29₹1.31₹0.65₹-0.60₹0.10₹0.13₹-5.40₹-6.76₹-6.88₹-4.82

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales60 Cr62 Cr80 Cr135 Cr172 Cr155 Cr169 Cr187 CrSign in for TTM
Operating expenses (approx.)55 Cr56 Cr66 Cr110 Cr138 Cr136 Cr151 Cr187 CrSign in for TTM
EBITDA4 Cr5 Cr13 Cr25 Cr34 Cr20 Cr18 Cr0.17 CrSign in for TTM
OPM %7.2%8.6%16.5%18.8%19.8%12.8%10.8%0.1%Sign in for TTM
Other income1 Cr0.95 Cr0.73 Cr1 Cr0.57 Cr2 Cr0.70 Cr2 CrSign in for TTM
Interest0.37 Cr0.77 Cr0.37 Cr2 Cr3 Cr5 Cr6 Cr11 CrSign in for TTM
Depreciation3 Cr4 Cr4 Cr5 Cr7 Cr9 Cr9 Cr17 CrSign in for TTM
Profit before tax2 Cr1 Cr9 Cr19 Cr24 Cr8 Cr3 Cr-28 CrSign in for TTM
Tax %6.8%37.2%24.6%28.2%27.2%31.1%77.9%11.7%Sign in for TTM
Net profit2 Cr0.86 Cr7 Cr14 Cr18 Cr6 Cr0.62 Cr-25 CrSign in for TTM
EPS (₹)₹3.08₹1.41₹10.99₹19.56₹18.87₹6.23₹0.22₹-23.84Sign in for TTM
Dividend payout %———4.5%4.4%16.8%0.0%—Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital6 Cr6 Cr6 Cr7 Cr9 Cr9 Cr10 Cr10 Cr
Reserves49 Cr49 Cr56 Cr76 Cr138 Cr219 Cr223 Cr224 Cr
Borrowings5 Cr6 Cr10 Cr51 Cr97 Cr109 Cr47 Cr60 Cr
Other liabilities13 Cr13 Cr25 Cr31 Cr44 Cr39 Cr115 Cr130 Cr
Total liabilities74 Cr75 Cr97 Cr164 Cr288 Cr377 Cr419 Cr424 Cr
Fixed assets (net)24 Cr24 Cr38 Cr64 Cr95 Cr102 Cr282 Cr273 Cr
CWIP2 Cr2 Cr7 Cr20 Cr88 Cr144 Cr0.0000 Cr4 Cr
Investments5 Cr6 Cr0.0000 Cr0.04 Cr0.0000 Cr3 Cr3 Cr3 Cr
Other assets8 Cr38 Cr42 Cr43 Cr101 Cr124 Cr130 Cr137 Cr
Total assets74 Cr75 Cr97 Cr164 Cr288 Cr377 Cr419 Cr424 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———1 Cr16 Cr-8 Cr27 Cr11 Cr
Cash from investing———-46 Cr-105 Cr-73 Cr-44 Cr-11 Cr
Cash from financing———46 Cr89 Cr82 Cr16 Cr-0.62 Cr
Net cash flow———1 Cr0.08 Cr0.78 Cr-2 Cr-0.47 Cr
Free cash flow (OCF − Capex)———-43 Cr-90 Cr-79 Cr-18 Cr-0.61 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %1.8%1.9%12.3%15.2%11.1%3.3%3.0%-5.8%
ROE %0.0%0.0%0.0%0.0%0.0%2.4%0.2%-7.3%
Debtor days018012271108128——
Inventory days69696730398310793
Days payable13291165118120132——
Cash conversion cycle-6315824-17277810793
Debt / equity0.100.110.160.610.790.530.180.25
Current ratio0.472.101.230.931.501.621.301.03
Net debt / EBITDA1.241.120.731.942.785.362.56345.34

Compare with peers

Loading peers…